Toll Free: 1-888-928-9744

Pharma Mar, S.A. - Product Pipeline Review - 2015

Published: Jul, 2015 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Pharma Mar, S.A. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Pharma Mar, S.A. - Product Pipeline Review - 2015', provides an overview of the Pharma Mar, S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pharma Mar, S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Pharma Mar, S.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Pharma Mar, S.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Pharma Mar, S.A.'s pipeline products

Reasons to buy

- Evaluate Pharma Mar, S.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Pharma Mar, S.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Pharma Mar, S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Pharma Mar, S.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pharma Mar, S.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Pharma Mar, S.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Pharma Mar, S.A. Snapshot 5 Pharma Mar, S.A. Overview 5 Key Information 5 Key Facts 5 Pharma Mar, S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Pharma Mar, S.A. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pharma Mar, S.A. - Pipeline Products Glance 11 Pharma Mar, S.A. - Late Stage Pipeline Products 11 Pre-Registration Products/Combination Treatment Modalities 11 Phase III Products/Combination Treatment Modalities 12 Pharma Mar, S.A. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Pharma Mar, S.A. - Drug Profiles 15 trabectedin 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 lurbinectedin 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 plitidepsin 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 PM-060184 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Pharma Mar, S.A. - Pipeline Analysis 26 Pharma Mar, S.A. - Pipeline Products by Target 26 Pharma Mar, S.A. - Pipeline Products by Route of Administration 27 Pharma Mar, S.A. - Pipeline Products by Molecule Type 28 Pharma Mar, S.A. - Pipeline Products by Mechanism of Action 29 Pharma Mar, S.A. - Recent Pipeline Updates 30 Pharma Mar, S.A. - Dormant Projects 37 Pharma Mar, S.A. - Discontinued Pipeline Products 38 Discontinued Pipeline Product Profiles 38 ES-285 38 elisidepsin 38 Pharma Mar, S.A. - Company Statement 39 Pharma Mar, S.A. - Locations And Subsidiaries 42 Head Office 42 Other Locations & Subsidiaries 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 43 Disclaimer 44
List of Tables
Pharma Mar, S.A., Key Information 5 Pharma Mar, S.A., Key Facts 5 Pharma Mar, S.A. - Pipeline by Indication, 2015 7 Pharma Mar, S.A. - Pipeline by Stage of Development, 2015 9 Pharma Mar, S.A. - Monotherapy Products in Pipeline, 2015 10 Pharma Mar, S.A. - Pre-Registration, 2015 11 Pharma Mar, S.A. - Phase III, 2015 12 Pharma Mar, S.A. - Phase II, 2015 13 Pharma Mar, S.A. - Phase I, 2015 14 Pharma Mar, S.A. - Pipeline by Target, 2015 26 Pharma Mar, S.A. - Pipeline by Route of Administration, 2015 27 Pharma Mar, S.A. - Pipeline by Molecule Type, 2015 28 Pharma Mar, S.A. - Pipeline Products by Mechanism of Action, 2015 29 Pharma Mar, S.A. - Recent Pipeline Updates, 2015 30 Pharma Mar, S.A. - Dormant Developmental Projects,2015 37 Pharma Mar, S.A. - Discontinued Pipeline Products, 2015 38 Pharma Mar, S.A., Subsidiaries 42



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify